SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006758
Filing Date
2021-05-11
Accepted
2021-05-11 08:07:27
Documents
80
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20210331x10q.htm 10-Q 1478016
2 EX-31.1 aplt-20210331ex311c556eb.htm EX-31.1 9684
3 EX-31.2 aplt-20210331ex312f21a8d.htm EX-31.2 9677
4 EX-32.1 aplt-20210331ex321eeb343.htm EX-32.1 6280
5 EX-32.2 aplt-20210331ex32259a581.htm EX-32.2 5924
  Complete submission text file 0001558370-21-006758.txt   6919708

Data Files

Seq Description Document Type Size
6 EX-101.INS aplt-20210331.xml EX-101.INS 1542365
7 EX-101.SCH aplt-20210331.xsd EX-101.SCH 59714
8 EX-101.CAL aplt-20210331_cal.xml EX-101.CAL 47168
9 EX-101.DEF aplt-20210331_def.xml EX-101.DEF 212181
10 EX-101.LAB aplt-20210331_lab.xml EX-101.LAB 475984
11 EX-101.PRE aplt-20210331_pre.xml EX-101.PRE 387317
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 21909701
SIC: 2834 Pharmaceutical Preparations